PARP Inhibitors: Breast Cancer’s Breakthrough and Resistance
In recent years, poly(ADP-ribose) polymerase inhibitors (PARPi) have revolutionized the landscape of cancer therapy, particularly in the management of breast cancers harboring BRCA1 and BRCA2...
















